Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6850
+0.0150 (0.90%)
NASDAQ· Last Trade: Jun 12th, 1:05 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors